CRSP – crispr therapeutics ag - common shares (US:NASDAQ)
Stock Stats
News
5/9
12:11 pm
crsp
Low
CRISPR Therapeutics AG (NASDAQ: CRSP) had its price target lowered by analysts at Wells Fargo & Company from $70.00 to $65.00. They now have an "equal weight" rating on the stock.
5/9
11:09 am
crsp
Low
CRISPR Therapeutics AG (NASDAQ: CRSP) had its price target lowered by analysts at Barclays PLC from $80.00 to $67.00. They now have an "equal weight" rating on the stock.
5/9
11:09 am
crsp
Low
CRISPR Therapeutics AG (NASDAQ: CRSP) had its "neutral" rating re-affirmed by analysts at Cantor Fitzgerald.
5/9
10:27 am
crsp
Low
Crispr Therapeutics Q1 Earnings: Casgevy Launch Tip Of Gene Editing Iceberg [Seeking Alpha]
5/9
10:11 am
crsp
Low
CRISPR Therapeutics AG (NASDAQ: CRSP) had its price target lowered by analysts at Needham & Company LLC from $90.00 to $88.00. They now have a "buy" rating on the stock.
5/8/2024
04:11 pm
CRSP
-3.5%
BEAT
2/21/2024
07:30 am
CRSP
5.6%
BEAT
11/6/2023
04:15 pm
CRSP
14.9%
BEAT
5/9
12:02 pm
Maintains
Equal-Weight
Equal-Weight
Wells Fargo
Low
-0.5%
5/9
12:02 pm
Maintains
Equal-Weight
Equal-Weight
Wells Fargo
Low
-0.5%
5/9
11:09 am
Reiterates
Neutral
Cantor Fitzgerald
Low
-0.5%
5/9
11:00 am
Reiterates
Neutral
Cantor Fitzgerald
Low
-0.7%
5/9
10:49 am
Maintains
Equal-Weight
Equal-Weight
Barclays
Low
-0.5%
5/8
04:21 pm
crsp
Low
Form 10-Q CRISPR Therapeutics AG For: Mar 31
5/8
04:16 pm
crsp
Low
Form 8-K CRISPR Therapeutics AG For: May 08
4/17
05:45 pm
crsp
Low
Form 4 CRISPR Therapeutics AG For: Apr 15 Filed by: Kulkarni Samarth
4/15
04:25 pm
crsp
Low
Form 144 CRISPR Therapeutics AG Filed by: Kulkarni Samarth
4/10
11:59 am
crsp
Low
Form SC 13G/A CRISPR Therapeutics AG Filed by: Capital International Investors
Show more
Top News Gainers
11/19 CRISPR Therapeutics down 4% premarket on initial CTX001 data [Seeking Alpha] 19.1%
2/28 Can CRISPR Therapeutics Double Your Money in 2020? [The Motley Fool] 13.1%
10/28 Q3/2019 9/30/2019 EPS 2.400 ZacksConsensus N/A ActVsEst N/A - N/A 12.5%
8/5 Form 4 CRISPR Therapeutics AG For: Aug 01 Filed by: Ho Tony W 7.5%
2/7 First CRISPR Gene Editing Trial in Cancer Patients Shows Promising Results [The Motley Fool] 6.8%
12/2 Form 4 CRISPR Therapeutics AG For: Dec 01 Filed by: Kulkarni Samarth 6.3%
11/22 Form 8-K CRISPR Therapeutics AG For: Nov 19 6.1%
10/30 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at TheStreet from a "d" rating to a "c" rating. 5.9%
6/6 Form 8-K CRISPR Therapeutics AG For: Jun 06 5.6%
4/24 Form DEF 14A CRISPR Therapeutics AG For: Jun 11 5.5%
Top News Decliners
11/20 CRISPR Therapeutics Announces Pricing of Public Offering of Common Shares -10.6%
3/31 Form 8-K CRISPR Therapeutics AG For: Mar 31 -10.4%
8/3 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at BidaskClub from a "hold" rating to a "buy" rating. -10.2%
12/27 Form 8-K CRISPR Therapeutics AG For: Dec 27 -7.5%
12/6 Crispr Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Wells Fargo & Co. -7.1%
2/21 Crispr Therapeutics AG (NASDAQ: CRSP) was upgraded by analysts at BidaskClub from a "strong sell" rating to a "sell" rating. -6.5%
10/1 CRISPR Therapeutics to Present at Upcoming Investor Conferences -6.3%
9/25 Is CRISPR Therapeutics a Buy? [The Motley Fool] -5.9%
2/13 Crispr Therapeutics AG (NASDAQ: CRSP) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $72.50 price target on the stock. -5.6%
6/19 Form 4 CRISPR Therapeutics AG For: Jun 17 Filed by: Kulkarni Samarth -5.6%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3